Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Carcinoma (RCC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05935748
What this trial is testing

Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)

Who this might be right for
ccRCCClear Cell Renal Cell CarcinomaKidney Cancer+18 more
NiKang Therapeutics, Inc. 18
Not applicableStudy completedNCT00610012
What this trial is testing

Tumor Registry of Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
iOMEDICO AG 1,500
Large-scale testing (Phase 3)Active Not RecruitingNCT03091192
What this trial is testing

Savolitinib vs. Sunitinib in MET-driven PRCC.

Who this might be right for
CarcinomaCarcinoma, Renal CellKidney Neoplasms+5 more
AstraZeneca 60
Very early researchWithdrawnNCT06708936
What this trial is testing

KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)
Kousai Bio Co., Ltd.
Testing effectiveness (Phase 2)Active Not RecruitingNCT05411081
What this trial is testing

Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial

Who this might be right for
Metastatic Papillary Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
National Cancer Institute (NCI) 200
Early research (Phase 1)Study completedNCT02219711
What this trial is testing

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Mirati Therapeutics Inc. 193
Testing effectiveness (Phase 2)Ended earlyNCT03207867
What this trial is testing

NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma

Who this might be right for
NSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more
Novartis Pharmaceuticals 315
Testing effectiveness (Phase 2)Study completedNCT03126110
What this trial is testing

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 145
Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Testing effectiveness (Phase 2)Looking for participantsNCT07097935
What this trial is testing

Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd. 104
Testing effectiveness (Phase 2)Ended earlyNCT00934440
What this trial is testing

Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Kansas Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT00121251
What this trial is testing

Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer

Who this might be right for
Recurrent Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7Stage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Ended earlyNCT00982657
What this trial is testing

A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Solid Tumor
Pfizer 34
Large-scale testing (Phase 3)Active Not RecruitingNCT05522231
What this trial is testing

Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2)

Who this might be right for
Advanced Renal Cell Carcinoma
Hutchmed 265
Early research (Phase 1)Active Not RecruitingNCT03872947
What this trial is testing

TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorColorectal CancerCholangiocarcinoma+9 more
Toray Industries, Inc 138
Testing effectiveness (Phase 2)UnknownNCT03047525
What this trial is testing

Study of DC-CTL Combined With CIK for Advanced Solid Tumor

Who this might be right for
Colorectal CancerRenal Cell CarcinomaNasopharyngeal Carcinoma+1 more
Xiaoyi Huang 200
Testing effectiveness (Phase 2)WithdrawnNCT05176288
What this trial is testing

Avelumab, Palbociclib and Axitinib in Advanced RCC

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma
Bradley A. McGregor, MD
Early research (Phase 1)Study completedNCT03319459
What this trial is testing

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

Who this might be right for
HER2 Positive Gastric CancerColorectal CancerHead and Neck Squamous Cell Carcinoma+8 more
Fate Therapeutics 44
Large-scale testing (Phase 3)Study completedNCT01613846
What this trial is testing

Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II)

Who this might be right for
Renal Cell Carcinoma
Technical University of Munich 544
Testing effectiveness (Phase 2)Active Not RecruitingNCT03308396
What this trial is testing

Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer

Who this might be right for
Advanced Kidney CancerKidney CancerClear Cell Renal Cell Carcinoma
Ajjai Alva, MD 57
Next Page